H. Lundbeck, new clinical data on Ebixa®

H. Lundbeck A/S’s American partner Forest Laboratories, Inc. has today announced new clinical data from a phase III study on Ebixa® in combination with donepezil (Aricept®). Please find below the release issued today by Forest Laboratories regarding the results of the clinical trial.


Documents & Links